4//SEC Filing
Shafer Bradford J 4
Accession 0001179110-18-010467
CIK 0001583107other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 7:46 PM ET
Size
8.6 KB
Accession
0001179110-18-010467
Insider Transaction Report
Form 4
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
- Sale
Ordinary Shares
2018-08-07$28.03/sh−4,127$115,686→ 123,479 total - Sale
Ordinary Shares
2018-08-07$28.99/sh−1,818$52,707→ 127,606 total - Sale
Ordinary Shares
2018-08-08$27.85/sh−25,355$706,182→ 98,124 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices from $28.60 to $29.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices from $28.015 to $28.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices from $27.63 to $28.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302448
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 7:46 PM ET
- Size
- 8.6 KB